NOVELSTEM INTERNATIONAL
NOVELSTEM INTERNATIONAL
Social Links:
Website Url:
http://www.novelstem.com
Status:
Active
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Apple Mobile Web Clips Icon Content Delivery Network Microsoft Exchange Online Office 365 Mail GoDaddy DNS
Current Employees Featured
Official Site Inspections
http://www.novelstem.com
- Host name: 147.62.236.23.bc.googleusercontent.com
- IP address: 23.236.62.147
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
More informations about "NovelStem International"
Home | NovelStem
Dec 14, 2022 · NovelStem International Corp. focuses on the development and commercialization of diagnostic technology that can predict patients’ anti-cancer drug resistance, allowing for …See details»
Leadership - NovelStem
Mr. Richman is a life science executive with significant leadership, operational and strategic experience from over 25 years in the field. He is currently CEO of Gain Therapeutics, …See details»
NovelStem Now an SEC-Reporting Company, Secures …
Oct 13, 2022 · NovelStem owns a 30% stake in NewStem Ltd. which is advancing its novel stem-cell-based diagnostic technology for predicting patients’ resistance to cancer therapies, …See details»
NovelStem International Company Description - Stock Analysis
Nov 18, 2024 · NovelStem International Corp., a development stage biotechnology holding company, focuses on development and commercialization of stem cell-based diagnostic …See details»
NovelStem International - Crunchbase Company …
NovelStem International is a provider of diagnostic technology. They provide biomedical applications in developmental biology and reproductive medicine, …See details»
NovelStem International Corp. (NSTM) - Stock Analysis
Nov 15, 2024 · NovelStem International Corp., a development stage biotechnology holding company, focuses on development and commercialization of stem cell-based diagnostic …See details»
NovelStem Announces NewStem, Ltd. Was Selected by Illumina …
Sep 20, 2021 · NewStem has developed a novel stem-cell-based technology platform for the development of therapeutics and diagnostics. Using this technology, NewStem has identified …See details»
NSTM Stock Price Quote | Morningstar
Nov 8, 2024 · See the latest NovelStem International Corp stock price (NSTM:PINX), related news, valuation, dividends and more to help you make your investing decisions.See details»
News - NovelStem
Dec 1, 2020 · NovelStem Announces FDA Pre-Submission and EMA In Vitro Diagnostic Device Filing for RevolutionarySee details»
NovelStem - Products, Competitors, Financials, Employees, …
NovelStem International Corp. specializes in the development and commercialization of diagnostic technologies in the life sciences sector. The company offers diagnostic solutions that predict …See details»
NovelStem, Focused on a Patented Genetic Platform Technology …
Mar 31, 2023 · NovelStem owns a 30.58% equity interest in NewStem Ltd. which is advancing its novel stem-cell-based diagnostic technology for predicting patients' resistance to cancer …See details»
NovelStem Increases NewStem Ownership to 33% as NewStem …
Dec 1, 2020 · NovelStem has completed the final $1M tranche of its NewStem investment, increasing its ownership to 33%, following NewStem’s successful, on-time completion of all …See details»
NovelStem Announces NewStem Selected by Illumina for its …
Sep 20, 2021 · Illumina Accelerator provides selected companies with access to seed investment, access to Illumina sequencing systems and reagents, as well as business guidance, genomics …See details»
News - NovelStem
Apr 21, 2024 · NovelStem Increases NewStem Ownership to 33% as NewStem Prepares for First-Half 2021 FDA Filing for Approval of its Stem-Cell Based Anti-Cancer Drug Resistance …See details»
Jerusalem-based NewStem Ltd. Selected for the Global Illumina ...
Sep 29, 2021 · NewStem, along with six other genomic companies, was selected by Illumina for its global Illumina Accelerator. NewStem Ltd main investor, NovelStem International Corp. m …See details»
NovelStem Increases NewStem Ownership to 27.3% Following …
Dec 16, 2019 · NovelStem Increases NewStem Ownership to 27.3% Following Achievement of Development Milestones for Stem-Cell-Based Cancer Treatments Resistance Diagnostic …See details»
Novelstem International Corp. total equity 2023 | Statista
Nov 1, 2024 · The total equity of Novelstem International Corp. with headquarters in the United States amounted to -1.95 million U.S. dollars in 2023. The reported fiscal year ends on …See details»
NovelStem Increases NewStem Ownership to 33% as NewStem …
Dec 1, 2020 · NovelStem recently increased its ownership to 33% from 27.3% based upon completion of an additional $1M investment on top of $3M that was invested prior, for a total …See details»
Characterization of three novel stem rot pathogens and their ...
Apr 8, 2024 · In this study, three novel pathogens causing C. deserticola stem rot were isolated, identified and pathogenicity tested, namely Fusarium solani CPF1, F. proliferatum CPF2, and …See details»
NovelStem Announces NewStem, Ltd. was Selected by Illumina for …
Sep 20, 2021 · NovelStem owns an approximate 30% stake in NewStem Ltd. which is advancing its novel stem-cell-based diagnostic technology for predicting patients’ resistance to cancer …See details»